Seguir
Evangelos Liberopoulos
Evangelos Liberopoulos
Dirección de correo verificada de med.uoa.gr - Página principal
Título
Citado por
Citado por
Año
Effects of thyroid dysfunction on lipid profile
CV Rizos, MS Elisaf, EN Liberopoulos
The open cardiovascular medicine journal 5, 76, 2011
5192011
Diabetes mellitus and electrolyte disorders
G Liamis, E Liberopoulos, F Barkas, M Elisaf
World Journal of Clinical Cases: WJCC 2 (10), 488, 2014
4382014
Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?
SG Tsouli, EN Liberopoulos, DP Mikhailidis, VG Athyros, MS Elisaf
Metabolism 55 (10), 1293-1301, 2006
3802006
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
VG Athyros, DP Mikhailidis, TP Didangelos, OI Giouleme, ...
Current medical research and opinion 22 (5), 873-883, 2006
3332006
“European panel on low density lipoprotein (LDL) subclasses”: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses
D P Mikhailidis, M Elisaf, M Rizzo, K Berneis, B Griffin, A Zambon, ...
Current vascular pharmacology 9 (5), 533-571, 2011
3242011
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a …
VG Athyros, DP Mikhailidis, EN Liberopoulos, AI Kakafika, A Karagiannis, ...
Nephrology Dialysis Transplantation 22 (1), 118-127, 2007
2862007
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related …
VG Athyros, TK Alexandrides, H Bilianou, E Cholongitas, M Doumas, ...
Metabolism 71, 17-32, 2017
2812017
Multiple actions of high-density lipoprotein
M Florentin, EN Liberopoulos, AS Wierzbicki, DP Mikhailidis
Current opinion in cardiology 23 (4), 370-378, 2008
2802008
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ...
The lancet Diabetes & endocrinology 7 (8), 618-628, 2019
2422019
Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease …
VG Athyros, EN Liberopoulos, DP Mikhailidis, AA Papageorgiou, ...
Angiology 58 (6), 689-697, 2007
2102007
Familial hypercholesterolaemia: a global call to arms
AJ Vallejo-Vaz, SRK Seshasai, D Cole, GK Hovingh, JJP Kastelein, ...
Atherosclerosis 243 (1), 257-259, 2015
2042015
How safe is the use of thiazolidinediones in clinical practice?
CV Rizos, M Elisaf, DP Mikhailidis, EN Liberopoulos
Expert opinion on drug safety 8 (1), 15-32, 2009
2002009
Diagnosis and management of the metabolic syndrome in obesity
EN Liberopoulos, DP Mikhailidis, MS Elisaf
Obesity reviews 6 (4), 283-296, 2005
1952005
Novel roles of vitamin D in disease: what is new in 2011?
S Makariou, EN Liberopoulos, M Elisaf, A Challa
European journal of internal medicine 22 (4), 355-362, 2011
1932011
Overview of the current status of familial hypercholesterolaemia care in over 60 countries-The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
AJ Vallejo-Vaz, M De Marco, CAT Stevens, A Akram, T Freiberger, ...
Atherosclerosis 277, 234-255, 2018
1892018
Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial
M Szarek, HD White, GG Schwartz, M Alings, DL Bhatt, VA Bittner, ...
Journal of the American College of Cardiology 73 (4), 387-396, 2019
1832019
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ...
The Lancet 398 (10312), 1713-1725, 2021
1712021
Dyslipidemia in patients with thyroid disorders
EN Liberopoulos, MS Elisaf
HORMONES-ATHENS- 1, 218-223, 2002
1642002
Statin-associated adverse effects beyond muscle and liver toxicity
DN Kiortsis, TD Filippatos, DP Mikhailidis, MS Elisaf, EN Liberopoulos
Atherosclerosis 195 (1), 7-16, 2007
1632007
A review of the metabolic effects of sibutramine
TD Filippatos, DN Kiortsis, EN Liberopoulos, DP Mikhailidis, MS Elisaf
Current medical research and opinion 21 (3), 457-466, 2005
1442005
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20